Daam2 driven degradation of VHL promotes gliomagenesis
Von Hippel-Landau (VHL) protein is a potent tumor suppressor regulating numerous pathways that drive cancer, but mutations in VHL are restricted to limited subsets of malignancies. Here we identified a novel mechanism for VHL suppression in tumors that do not have inactivating mutations. Using devel...
Main Authors: | Wenyi Zhu, Saritha Krishna, Cristina Garcia, Chia-Ching John Lin, Bartley D Mitchell, Kenneth L Scott, Carrie A Mohila, Chad J Creighton, Seung-Hee Yoo, Hyun Kyoung Lee, Benjamin Deneen |
---|---|
Format: | Article |
Language: | English |
Published: |
eLife Sciences Publications Ltd
2017-10-01
|
Series: | eLife |
Subjects: | |
Online Access: | https://elifesciences.org/articles/31926 |
Similar Items
-
The SWI/SNF Protein PBRM1 Restrains VHL-Loss-Driven Clear Cell Renal Cell Carcinoma
by: Amrita M. Nargund, et al.
Published: (2017-03-01) -
PDGF-B-driven gliomagenesis can occur in the absence of the proteoglycan NG2
by: Calzolari Filippo, et al.
Published: (2010-10-01) -
Placental defects lead to embryonic lethality in mice lacking the Formin and PCP proteins Daam1 and Daam2.
by: Masa-Aki Nakaya, et al.
Published: (2020-01-01) -
The role of protein arginine-methyltransferase 1 in gliomagenesis
by: Shan Wang, Xiaochao Tan, Bin Yang, Bin Yin, Jiangang Yuan, Boqin Qiang & Xiaozhong Peng*
Published: (2012-08-01) -
Friend or Foe: Paradoxical Roles of Autophagy in Gliomagenesis
by: Don Carlo Ramos Batara, et al.
Published: (2021-06-01)